Natural killer cells in innate immunity and cancer

被引：42

作者：

Becknell, Brian ^{[2
,4
]}

Caligiuri, Michael A. ^{[1
,3
,4
]}

机构：

[1] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA

[2] Ohio State Univ, Med Sci Program, Columbus, OH 43210 USA

[3] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA

[4] Ohio State Univ, Div Hematol Oncol, Dept Internal Med, Coll Med & Publ Hlth, Columbus, OH 43210 USA

来源：

JOURNAL OF IMMUNOTHERAPY | 2008年 / 31卷 / 08期

关键词：

D O I：

10.1097/CJI.0b013e318182de23

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：685 / 692

页数：8

共 84 条

[51] Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self [J].

Ruggeri, Loredana ;

Aversa, Franco ;

Martelli, Massimo F. ;

Velardi, Andrea .

IMMUNOLOGICAL REVIEWS, 2006, 214 :202-218

[52] Foxp3+CD25+CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease [J].

Sakaguchi, Shimon ;

Ono, Masahiro ;

Setoguchi, Ruka ;

Yagi, Haruhiko ;

Hori, Shohei ;

Fehervari, Zoltan ;

Shimizu, Jun ;

Takahashi, Takeshi ;

Nomura, Takashi .

IMMUNOLOGICAL REVIEWS, 2006, 212 :8-27

[53] Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia [J].

Salih, HR ;

Antropius, H ;

Gieseke, F ;

Lutz, SZ ;

Kanz, L ;

Rammensee, HG ;

Steinle, A .

BLOOD, 2003, 102 (04) :1389-1396

[54] Signaling pathways regulating CD44-dependent cytolysis in natural killer cells [J].

Sconocchia, G ;

Titus, JA ;

Segal, DM .

BLOOD, 1997, 90 (02) :716-725

[55] A phase I study of ultra low dose interleukin-2 and stem cell factor in patients with HIV infection or HIV and cancer [J].

Shah, Manisha H. ;

Freud, Aharon G. ;

Benson, Don M., Jr. ;

Ferkitich, Amy K. ;

Dezube, Bruce J. ;

Bernstein, Zale P. ;

Caligiuri, Michael A. .

CLINICAL CANCER RESEARCH, 2006, 12 (13) :3993-3996

[56] Cancer cells become susceptible to natural killer cell killing after exposure to histone deacetylase inhibitors due to glycogen synthase kinase-3-dependent expression of MHC class I-related chain A and B [J].

Skov, S ;

Pedersen, MT ;

Andresen, L ;

Straten, PT ;

Woetmann, A ;

Odum, N .

CANCER RESEARCH, 2005, 65 (23) :11136-11145

[57] NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer [J].

Smyth, MJ ;

Swann, J ;

Kelly, JM ;

Cretney, E ;

Yokoyama, WM ;

Diefenbach, A ;

Sayers, TJ ;

Hayakawa, Y .

JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (10) :1325-1335

[58] CD4+-CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer [J].

Smyth, MJ ;

Teng, MWL ;

Swann, J ;

Kyparissoudis, K ;

Godfrey, DI ;

Hayakawa, Y .

JOURNAL OF IMMUNOLOGY, 2006, 176 (03) :1582-1587

[59] New aspects of natural-killer-cell surveillance and therapy of cancer [J].

Smyth, MJ ;

Hayakawa, Y ;

Takeda, K ;

Yagita, H .

NATURE REVIEWS CANCER, 2002, 2 (11) :850-861

[60] An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum [J].

Smyth, MJ ;

Kelly, JM ;

Baxter, AG ;

Körner, H ;

Sedgwick, JD .

JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (09) :1611-1619

← 1 2 3 4 5 6 7 8 9 →